BDBM457868 (S)-2-(1-((6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrimidin-4-yl)amino)ethyl)-5-(3-hydroxyprop-1-yn-1-yl)-3-phenylquinazolin-4(3H)-one::US10751339, Example 34

SMILES C[C@H](Nc1ncnc(N)c1-c1nc(C)no1)c1nc2cccc(C#CCO)c2c(=O)n1-c1ccccc1

InChI Key InChIKey=USHTVIUFWXFMLN-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 457868   

LigandPNGBDBM457868((S)-2-(1-((6-amino-5-(3-methyl-1,2,4-oxadiazol-5-y...)
Affinity DataIC50: 770nMAssay Description:PI3K (p110α/p85α) (h) is incubated in assay buffer containing 10 μM phosphatidylinositol 4,5-bisphosphate and MgATP (concentration as ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

LigandPNGBDBM457868((S)-2-(1-((6-amino-5-(3-methyl-1,2,4-oxadiazol-5-y...)
Affinity DataIC50: 160nMAssay Description:PI3K (p110β/p85α) (h) is incubated in assay buffer containing 10 μM phosphatidylinositol-4,5-bisphosphate and MgATP (concentration as ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

LigandPNGBDBM457868((S)-2-(1-((6-amino-5-(3-methyl-1,2,4-oxadiazol-5-y...)
Affinity DataIC50: 4nMAssay Description:PI3K (p110δ/p85α) (h) is incubated in assay buffer containing 10 μM phosphatidylinositol-4, 5-bisphosphate and MgATP (concentration as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

LigandPNGBDBM457868((S)-2-(1-((6-amino-5-(3-methyl-1,2,4-oxadiazol-5-y...)
Affinity DataIC50: 192nMAssay Description:PI3K (p120γ) (h) is incubated in assay buffer containing 10 μM phosphatidylinositol-4, 5-bisphosphate and MgATP (concentration as required)...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM457868((S)-2-(1-((6-amino-5-(3-methyl-1,2,4-oxadiazol-5-y...)
Affinity DataIC50: 3.00E+4nMAssay Description:Voltage clamp protocol: Computer software was used to set voltage clamp protocols. In whole-cell model, cells were held at −80 mV, first depola...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent